Trimethoprim-sulphamethoxazole: long-term therapy and folate levels.
D000667:Ampicillin / Q000627:therapeutic use; D000748:Anemia, Macrocytic / Q000139:chemically induced; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000927:Anticonvulsants / Q000009:adverse effects; D001681:Biological Assay; D002908:Chronic Disease; D004338:Drug Combinations; D004912:Erythrocytes / Q000032:analysis; D005492:Folic Acid / Q000097:blood*; D005493:Folic Acid Antagonists / Q000008:administration & dosage*; D005494:Folic Acid Deficiency / Q000150:complications; D006801:Humans; D007780:Lacticaseibacillus casei / Q000378:metabolism; D011743:Pyrimidines / Q000008:administration & dosage*; D012141:Respiratory Tract Infections / Q000097:blood / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014295:Trimethoprim / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D000667:Ampicillin; D005492:Folic Acid; D014295:Trimethoprim; D013420:Sulfamethoxazole